Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors

Clinical trial NCT03509012 · COMPLETED

Trial details

NCT number: NCT03509012
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell of Head and Neck Carcinoma, Non-Small-Cell Lung Small Cell Lung Carcinoma

Start date: 2018-05-02
Primary completion: 2020-12-31
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.